Difference between revisions of "Reactive gastropathy"

From Libre Pathology
Jump to navigation Jump to search
 
(14 intermediate revisions by the same user not shown)
Line 1: Line 1:
{{ Infobox diagnosis
{{ Infobox diagnosis
| Name      = {{PAGENAME}}
| Name      = {{PAGENAME}}
| Image      = Reactive_gastropathy_-_intermed_mag.jpg
| Image      = Reactive_gastropathy_--_intermed_mag.jpg
| Width      =
| Width      =
| Caption    = Reactive gastropathy. [[H&E stain]].
| Caption    = Reactive gastropathy. [[H&E stain]].
| Synonyms  = chemical gastritis, chemical gastropathy, NSAID gastropathy (if due to a NSAID)
| Micro      = foveolar hyperplasia - esp. tortuosity of glands in the "neck" region (S shaped glands), smooth muscle hyperplasia, scant inflammatory cells, +/-edema, +/-erosions
| Micro      = foveolar hyperplasia - esp. tortuosity of glands in the "neck" region (S shaped glands), smooth muscle hyperplasia, scant inflammatory cells, +/-edema, +/-erosions
| Subtypes  =
| Subtypes  =
| LMDDx      =
| LMDDx      = [[hyperplastic polyp of the stomach]], [[collagenous gastritis]], [[amyloidosis]], [[chronic gastritis]]
| Stains    =
| Stains    =
| IHC        =
| IHC        =
Line 15: Line 16:
| Grossing  =
| Grossing  =
| Site      = [[stomach]]
| Site      = [[stomach]]
| Assdx      =
| Assdx      = [[osteoarthritis]] (treated with NSAIDs)
| Syndromes  =
| Syndromes  =
| Clinicalhx = classically NSAID use or alcohol use
| Clinicalhx = classically [[NSAID]] use or alcohol use
| Signs      =
| Signs      =
| Symptoms  =
| Symptoms  =
Line 27: Line 28:
| Other      =
| Other      =
| ClinDDx    = [[gastritis]]
| ClinDDx    = [[gastritis]]
}}
{{ Infobox external links
| Name          = {{PAGENAME}}
| EHVSC          = 10177
| pathprotocols  =
| wikipedia      = reactive gastropathy
| pathoutlines  =
}}
}}
'''Reactive gastropathy''', abbreviated '''RG''', a relatively common pathology of the [[stomach]]. It is also known as '''chemical gastropathy''',<ref name=pmid16939055>{{Cite journal  | last1 = Genta | first1 = RM. | title = Differential diagnosis of reactive gastropathy. | journal = Semin Diagn Pathol | volume = 22 | issue = 4 | pages = 273-83 | month = Nov | year = 2005 | doi =  | PMID = 16939055 }}</ref> and incorrectly referred to as '''chemical gastritis''' ([[Reactive gastropathy#Relation to gastritis|see below]]).
'''Reactive gastropathy''', abbreviated '''RG''', a relatively common pathology of the [[stomach]]. It is also known as '''chemical gastropathy''',<ref name=pmid16939055>{{Cite journal  | last1 = Genta | first1 = RM. | title = Differential diagnosis of reactive gastropathy. | journal = Semin Diagn Pathol | volume = 22 | issue = 4 | pages = 273-83 | month = Nov | year = 2005 | doi =  | PMID = 16939055 }}</ref> and incorrectly referred to as '''chemical gastritis''' ([[Reactive gastropathy#Relation to gastritis|see below]]).
''NSAID gastropathy'' redirects to here.


==General==
==General==
Line 39: Line 49:
Etologic factors - associated with:<ref>ALS. 5 February 2009.</ref>
Etologic factors - associated with:<ref>ALS. 5 February 2009.</ref>
*Excess acid.
*Excess acid.
*[[EtOH]].
*[[EtOH|Alcohol use (excessive)]].
*Bile.
*Bile (reflux).
*[[H. pylori]].
**May be seen post-Bilroth II (distal gastrectomy).
*Drugs:<ref name=pmid16939055>{{Cite journal  | last1 = Genta | first1 = RM. | title = Differential diagnosis of reactive gastropathy. | journal = Semin Diagn Pathol | volume = 22 | issue = 4 | pages = 273-83 | month = Nov | year = 2005 | doi =  | PMID = 16939055 }}</ref>
*Drugs.<ref name=pmid16939055>{{Cite journal  | last1 = Genta | first1 = RM. | title = Differential diagnosis of reactive gastropathy. | journal = Semin Diagn Pathol | volume = 22 | issue = 4 | pages = 273-83 | month = Nov | year = 2005 | doi =  | PMID = 16939055 }}</ref>
**Iron (brown pigment on histology).
**Iron (brown pigment on histology).
**[[NSAID]]s - synergistic effect with corticosteroids.
**[[NSAID]]s - synergistic effect with corticosteroids.
**Steroids.<ref>URL: [http://www.cmej.org.za/index.php/cmej/article/view/2316/2190 http://www.cmej.org.za/index.php/cmej/article/view/2316/2190]. Accessed on: June 17, 2016.</ref>
Notes:
*[[H. pylori]] uncommon in RG.<ref name=pmid25238940>{{Cite journal  | last1 = Wolf | first1 = EM. | last2 = Plieschnegger | first2 = W. | last3 = Schmack | first3 = B. | last4 = Bordel | first4 = H. | last5 = Höfler | first5 = B. | last6 = Eherer | first6 = A. | last7 = Schulz | first7 = T. | last8 = Vieth | first8 = M. | last9 = Langner | first9 = C. | title = Evolving patterns in the diagnosis of reactive gastropathy: data from a prospective Central European multicenter study with proposal of a new histologic scoring system. | journal = Pathol Res Pract | volume = 210 | issue = 12 | pages = 847-54 | month = Dec | year = 2014 | doi = 10.1016/j.prp.2014.08.009 | PMID = 25238940 }}</ref>


Drugs that cause erosions and/or ulcers -- adapted from ''Genta'':<ref name=pmid16939055>{{Cite journal  | last1 = Genta | first1 = RM. | title = Differential diagnosis of reactive gastropathy. | journal = Semin Diagn Pathol | volume = 22 | issue = 4 | pages = 273-83 | month = Nov | year = 2005 | doi =  | PMID = 16939055 }}</ref>
Drugs that cause erosions and/or ulcers - adapted from ''Genta'':<ref name=pmid16939055>{{Cite journal  | last1 = Genta | first1 = RM. | title = Differential diagnosis of reactive gastropathy. | journal = Semin Diagn Pathol | volume = 22 | issue = 4 | pages = 273-83 | month = Nov | year = 2005 | doi =  | PMID = 16939055 }}</ref>


{| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto"
Line 53: Line 67:
! Indication for Rx
! Indication for Rx
|-
|-
| NSAIDs
| [[NSAID]]s
| common cause
| common cause
| pain, reduce cardiovascular risk
| pain, reduce cardiovascular risk
Line 63: Line 77:
| Potassium (KCl)
| Potassium (KCl)
| common cause
| common cause
| renal failure
| [[congestive heart failure]]<ref name=pmid25960118>{{Cite journal  | last1 = Weir | first1 = MR. | last2 = Espaillat | first2 = R. | title = Clinical perspectives on the rationale for potassium supplementation. | journal = Postgrad Med | volume = 127 | issue = 5 | pages = 539-48 | month = Jun | year = 2015 | doi = 10.1080/00325481.2015.1045814 | PMID = 25960118 }}</ref>
|-
|-
| Bisphophonates
| Bisphophonates
Line 71: Line 85:
| Ferrous sulfate
| Ferrous sulfate
| very common if symptomatic
| very common if symptomatic
| iron deficiency anemia
| iron deficiency [[anemia]]
|-
|-
| Chloroquine
| Chloroquine
Line 79: Line 93:
| Sodium polystyrene sulfonate (Kayexalate)
| Sodium polystyrene sulfonate (Kayexalate)
| rare
| rare
| renal failure patients
| [[renal failure]]
|}
|}


Line 113: Line 127:


===Images===
===Images===
<gallery>
Image: Reactive gastropathy -- very low mag.jpg | RG - very low mag. (WC/Nephron)
Image: Reactive gastropathy -- low mag.jpg | RG - low mag. (WC/Nephron)
Image: Reactive gastropathy - alt -- low mag.jpg | RG - low mag. (WC/Nephron)
Image: Reactive gastropathy -- intermed mag.jpg | RG - intermed. mag. (WC/Nephron)
Image: Reactive gastropathy - alt -- intermed mag.jpg | RG - intermed. mag. (WC/Nephron)
Image: Reactive gastropathy -- high mag.jpg | RG - high mag. (WC/Nephron)
</gallery>
<gallery>
<gallery>
Image: Reactive_gastropathy_-_low_mag.jpg | RG - low mag. (WC/Nephron)
Image: Reactive_gastropathy_-_low_mag.jpg | RG - low mag. (WC/Nephron)
Image: Reactive_gastropathy_-_intermed_mag.jpg | RG - intermed. mag. (WC/Nephron)
Image: Reactive_gastropathy_-_high_mag.jpg | RG - high mag. (WC/Nephron)
Image: Reactive_gastropathy_-_high_mag.jpg | RG - high mag. (WC/Nephron)
</gallery>
</gallery>


==Sign out==
==Sign out==
<pre>
Stomach, Antrum, Biopsy:
- Antral-type gastric mucosa with reactive gastropathy.
- NEGATIVE for Helicobacter-like organisms.
- NEGATIVE for intestinal metaplasia.
- NEGATIVE for dysplasia and NEGATIVE for malignancy.
</pre>
===Block letters===
<pre>
<pre>
STOMACH, BIOPSY:
STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH REACTIVE GASTROPATHY, SEE COMMENT.
- ANTRAL-TYPE GASTRIC MUCOSA WITH REACTIVE GASTROPATHY, SEE COMMENT.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.


Line 131: Line 163:
</pre>
</pre>


===Not well-developed===
====RG and mild chronic gastritis====
<pre>
STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH REACTIVE GASTROPATHY AND MILD CHRONIC
  INACTIVE INFLAMMATION.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
</pre>
 
====Not well-developed====
<pre>
<pre>
STOMACH, BIOPSY:
STOMACH, BIOPSY:
Line 137: Line 179:
- ANTRAL-TYPE GASTRIC MUCOSA WITH SMOOTH MUSCLE HYPERPLASIA,
- ANTRAL-TYPE GASTRIC MUCOSA WITH SMOOTH MUSCLE HYPERPLASIA,
   RARE GLAND TORTUOSITY AND NO SIGNFICANT INFLAMMATION, SEE COMMENT.
   RARE GLAND TORTUOSITY AND NO SIGNFICANT INFLAMMATION, SEE COMMENT.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.


Line 146: Line 188:
</pre>
</pre>


====Not well-developed with minimal inflammation====
<pre>
STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH SMOOTH MUSCLE HYPERPLASIA, RARE GLAND TORTUOSITY
  AND MINIMAL CHRONIC INACTIVE INFLAMMATION, SEE COMMENT.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
COMMENT:
The smooth muscle hyperplasia and rare gland tortuosity are suggestive of a reactive
gastropathy.
</pre>
=====Isolated smooth muscle prominence=====
<pre>
<pre>
STOMACH, BIOPSY:
STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH PROMINENT SMOOTH MUSCLE, OTHERWISE WITHIN NORMAL
- ANTRAL-TYPE GASTRIC MUCOSA WITH PROMINENT SMOOTH MUSCLE, OTHERWISE WITHIN NORMAL
LIMITS.
LIMITS.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.
</pre>
</pre>
Line 157: Line 214:
==See also==
==See also==
*[[Stomach]].
*[[Stomach]].
*[[Alcoholism]].


==References==
==References==

Latest revision as of 17:47, 17 June 2016

Reactive gastropathy
Diagnosis in short

Reactive gastropathy. H&E stain.
Synonyms chemical gastritis, chemical gastropathy, NSAID gastropathy (if due to a NSAID)
LM foveolar hyperplasia - esp. tortuosity of glands in the "neck" region (S shaped glands), smooth muscle hyperplasia, scant inflammatory cells, +/-edema, +/-erosions
LM DDx hyperplastic polyp of the stomach, collagenous gastritis, amyloidosis, chronic gastritis
Site stomach
Associated Dx osteoarthritis (treated with NSAIDs)
Clinical history classically NSAID use or alcohol use
Endoscopy erythema, +/-erosions, +/-bile reflux
Clin. DDx gastritis
Reactive gastropathy
External resources
EHVSC 10177
Wikipedia reactive gastropathy

Reactive gastropathy, abbreviated RG, a relatively common pathology of the stomach. It is also known as chemical gastropathy,[1] and incorrectly referred to as chemical gastritis (see below).

NSAID gastropathy redirects to here.

General

  • May be seen in the context of a previous resection/surgical reconstruction, e.g. Billroth II.

Epidemiology

General assocations:

  • Increases with age.[2]

Etologic factors - associated with:[3]

  • Excess acid.
  • Alcohol use (excessive).
  • Bile (reflux).
    • May be seen post-Bilroth II (distal gastrectomy).
  • Drugs.[1]
    • Iron (brown pigment on histology).
    • NSAIDs - synergistic effect with corticosteroids.
    • Steroids.[4]

Notes:

Drugs that cause erosions and/or ulcers - adapted from Genta:[1]

Drug Comment Indication for Rx
NSAIDs common cause pain, reduce cardiovascular risk
Corticosteroids synergistic effect with NSAIDs rheumatologic diseases + others
Potassium (KCl) common cause congestive heart failure[6]
Bisphophonates uncommon cause osteoporosis
Ferrous sulfate very common if symptomatic iron deficiency anemia
Chloroquine uncommon only in the context of malaria
Sodium polystyrene sulfonate (Kayexalate) rare renal failure

Relation to gastritis

  • May mimic a (true) gastritis symptomatically and visually in an endoscopic examination.
  • "Chemical gastritis" is misnomer. Etymologically, the -itis in gastritis, implies an inflammatory process. Chemical gastropathy is not (predominantly) an inflammatory process.
    • This type of confusion is not uncommon. Steatohepatitis is another example of this; it is not a process with significant inflammation yet, confusingly, carries the -itis ending.

Gross/endoscopic

Features:[7]

  • Antral erythema +/- erosions.
  • +/-Bile.

Microscopic

Features - triad:[8][1]

  1. Foveolar hyperplasia.
    • Tortuosity of glands in the "neck" region of the gastric glands.
    • Associated with "mucin depletion" - cytoplasm not clear -- as is usual.
  2. Smooth muscle fibre hyperplasia.
    • Abundant eosinophilic lamina propria.
  3. Scant acute & chronic inflammatory cells.

Additional features.

  • +/-Edema.
  • +/-Erosions.

Notes:

  • Triad rarely present; mild inflammation common.

DDx:

Images

  • RG - very low mag. (WC/Nephron)

  • RG - low mag. (WC/Nephron)

  • RG - low mag. (WC/Nephron)

  • RG - intermed. mag. (WC/Nephron)

  • RG - intermed. mag. (WC/Nephron)

  • RG - high mag. (WC/Nephron)

  • RG - low mag. (WC/Nephron)

  • RG - intermed. mag. (WC/Nephron)

  • RG - high mag. (WC/Nephron)

Sign out

Stomach, Antrum, Biopsy:
- Antral-type gastric mucosa with reactive gastropathy.
- NEGATIVE for Helicobacter-like organisms.
- NEGATIVE for intestinal metaplasia.
- NEGATIVE for dysplasia and NEGATIVE for malignancy.

Block letters

STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH REACTIVE GASTROPATHY, SEE COMMENT.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.

COMMENT:
This nonspecific finding may be due to a number of causes, including 
medications (especially NSAIDs), alcohol and bile reflux.

RG and mild chronic gastritis

STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH REACTIVE GASTROPATHY AND MILD CHRONIC
  INACTIVE INFLAMMATION.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.

Not well-developed

STOMACH, BIOPSY:
- BODY-TYPE GASTRIC MUCOSA WITHIN NORMAL LIMITS.
- ANTRAL-TYPE GASTRIC MUCOSA WITH SMOOTH MUSCLE HYPERPLASIA,
  RARE GLAND TORTUOSITY AND NO SIGNFICANT INFLAMMATION, SEE COMMENT.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.

COMMENT:
These findings are suggestive of a reactive gastropathy; however, gland 
corkscrewing is not evident.

Not well-developed with minimal inflammation

STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH SMOOTH MUSCLE HYPERPLASIA, RARE GLAND TORTUOSITY
  AND MINIMAL CHRONIC INACTIVE INFLAMMATION, SEE COMMENT.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.

COMMENT:
The smooth muscle hyperplasia and rare gland tortuosity are suggestive of a reactive
gastropathy.
Isolated smooth muscle prominence
STOMACH, BIOPSY:
- ANTRAL-TYPE GASTRIC MUCOSA WITH PROMINENT SMOOTH MUSCLE, OTHERWISE WITHIN NORMAL
LIMITS.
- NEGATIVE FOR HELICOBACTER-LIKE ORGANISMS.
- NEGATIVE FOR INTESTINAL METAPLASIA.
- NEGATIVE FOR DYSPLASIA AND NEGATIVE FOR MALIGNANCY.

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 Genta, RM. (Nov 2005). "Differential diagnosis of reactive gastropathy.". Semin Diagn Pathol 22 (4): 273-83. PMID 16939055.
  2. ↑ Maguilnik, I.; Neumann, WL.; Sonnenberg, A.; Genta, RM. (Aug 2012). "Reactive gastropathy is associated with inflammatory conditions throughout the gastrointestinal tract.". Aliment Pharmacol Ther. doi:10.1111/apt.12031. PMID 22928604.
  3. ↑ ALS. 5 February 2009.
  4. ↑ URL: http://www.cmej.org.za/index.php/cmej/article/view/2316/2190. Accessed on: June 17, 2016.
  5. ↑ Wolf, EM.; Plieschnegger, W.; Schmack, B.; Bordel, H.; Höfler, B.; Eherer, A.; Schulz, T.; Vieth, M. et al. (Dec 2014). "Evolving patterns in the diagnosis of reactive gastropathy: data from a prospective Central European multicenter study with proposal of a new histologic scoring system.". Pathol Res Pract 210 (12): 847-54. doi:10.1016/j.prp.2014.08.009. PMID 25238940.
  6. ↑ Weir, MR.; Espaillat, R. (Jun 2015). "Clinical perspectives on the rationale for potassium supplementation.". Postgrad Med 127 (5): 539-48. doi:10.1080/00325481.2015.1045814. PMID 25960118.
  7. ↑ Iacobuzio-Donahue, Christine A.; Montgomery, Elizabeth A. (2005). Gastrointestinal and Liver Pathology: A Volume in the Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 69. ISBN 978-0443066573.
  8. ↑ El-Zimaity. 18 October 2010.
  9. ↑ Iacobuzio-Donahue, Christine A.; Montgomery, Elizabeth A. (2005). Gastrointestinal and Liver Pathology: A Volume in the Foundations in Diagnostic Pathology Series (1st ed.). Churchill Livingstone. pp. 69. ISBN 978-0443066573.
Retrieved from "https://librepathology.org/w/index.php?title=Reactive_gastropathy&oldid=45045"